1 Comment
⭠ Return to thread

Given that they have precise data on who was injected with what, and on their health condition pre and post injection (series)... They might just treat everyone with that stuff and then find out by observation if cancer rates go down, or what kinds of cancers continue to escalate and which don't... At the same time, they would know which genetic makeup seems to respond best and least because they have (if they want) the DNA samples of most patients, either from past testing or, or and, from testing in the coming "season". They can monitor all sorts of parameters and developments should they be interested.

Expand full comment